1. Pink Sheet
  2. >>Rare Diseases

Califf: Rare Disease Hub Will Develop Methods To Guide Approvability Determinations

 
• By Sarah Karlin-Smith

The US FDA commissioner also said the hub is looking for an executive director who will work with the CBER and CDER heads, who will serve as co-leads. 

FDA Commissioner Robert Califf speaks at a webinar sponsored by the Alliance for a Stronger FDA
FDA Commissioner Robert Califf discussed the FDA's new rare disease hub during a 27 September Alliance for a Stronger FDA event. • Source: Screenshot from Alliance for Stronger FDA webinar

The US Food and Drug Administration’s new Rare Disease Innovation Hub will have three main functions, including methods development work that should ultimately help better determine whether a drug meets the approval threshold, FDA Commissioner Robert Califf said.

Key Takeaways

  • A main function of the FDA’s new Rare Disease Innovation Hub will be developing methods that will help make risk-benefit determinations, Commissioner Robert Califf said.

  • The...

During a 27 September Alliance for a Stronger FDA event, Califf said he was “really excited about the joint effort to develop methods” between the FDA’s Center for Drug Evaluation...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Rare Diseases

More from Pink Sheet

EMA Official Clarifies Benefits And Limitations Of Innovation Pathways

 
• By Eliza Slawther

A European Medicines Agency official provided an overview and update of the support the EMA offers developers of innovative products and discussed, among other things, its Innovation Task Force, Quality Innovation Group and a scientific advice pilot for clinical trials.

EU Emergency Response Authority Needs Bigger Budget To Address Health Threats, Says Industry

 
• By Eliza Slawther

The EU must renew the mandate of its Health Emergency Response Authority to support medicine stockpiles and enable agile manufacturing to combat antimicrobial resistance and chemical, biological, radiological and nuclear threats, says trade organization EUCOPE.